ask="0.5970"
ask_size="4000"
average_daily_volume="544275"
bid="0.3500"
bid_size="2000"
book_value="0.6320"
change="+0.0059"
change_from_200_day_moving_average="0.0386"
change_from_50_day_moving_average="-0.0260"
change_from_52_week_high="-0.8715"
change_From_52_week_low="0.2174"
change_in_percent="+1.0876%"
close="0.5484"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.6720"
ebitda="-18.47M"
eps_estimate_current_year="-0.7800"
eps_estimate_next_quarter="0.0000"
eps_estimate_next_year="-0.5700"
ex_dividend_date="N/A"
float_shares="29692000"
high="0.5530"
high_52_weeks="1.4199"
last_trade_date="3/2/2017"
last_trade_price="0.5484"
last_trade_size="2000"
last_trade_time="3:54pm"
low="0.5200"
low_52_weeks="0.3310"
market_capitalization="16.50M"
moving_average_200_day="0.5098"
moving_average_50_day="0.5744"
name="OncoGenex Pharmaceuticals Inc."
notes="N/A"
one_year_target_price="0.9000"
open="0.5441"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="+7.5756%"
percent_change_from_50_day_moving_average="-4.5285%"
percent_change_from_52_week_high="-61.3776%"
percent_change_from_52_week_low="+65.6797%"
previous_close="0.5425"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.8584"
price_per_sales="3.2243"
revenue="5.06M"
shares_outstanding="30086000"
short_ratio="1.1100"
stock_exchange="NCM"
symbol="OGXI"
volume="94498"
weeks_range_52="0.3310 - 1.4199"
